Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Dual Rx/OTC Status In US ‘Additional Condition’ Switch Proposal: Necessary Or Questionable?
FDA Shift In Requirements For OTC Switch Follow-On Approvals Also Discussed By Experts
Jun 30 2022
•
By
Malcolm Spicer
• Source: Shutterstock
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Policy & Regulation
More from Health